Cancer Biology & Genetics Program

The Christine Mayr Lab

Research

Christine Mayr
Christine Mayr, MD, PhD
My laboratory studies the regulatory and structural roles of mRNAs in the cytoplasm.

My laboratory studies the regulatory and structural roles of mRNAs in the cytoplasm. Specifically, we investigate how 3′UTRs regulate protein functions in a manner that is independent of protein abundance.

We found that inclusion or exclusion of the 3′UTR of an mRNA that encodes a transcription factor did not change how much of the transcription factor protein was expressed but determined the location of protein synthesis of the transcription factor as well as its induced gene expression program. Moreover, we observed that expression of a chromatin regulator from an mRNA with or without its 3′UTR resulted in similar expression of the protein in the nucleus but changed the enzymatic activity of the chromatin regulator in the nucleus.  

These examples illustrate that in addition to the coding sequence (which is translated into protein), other parts of mRNAs, specifically the 3′ untranslated region (3′UTR), can control protein activity and protein function in a manner that is independent of protein abundance. We are currently studying the mechanism by which 3′UTRs control protein activity. In the course of these studies, we found that 3′UTRs determine where in the cytoplasm an mRNA transcript is translated. Moreover, we found that the cytoplasm is highly compartmentalized into different translation environments. We identified several mRNA-based translation environments and have evidence that within these environments, mRNAs play major regulatory roles. We currently study the three mRNA-based translation environments that were discovered by us. They include TIS granules, the FXR1 network, and a poorly characterized environment generated by TIAL1 on the endoplasmic reticulum.

We are interested in the following questions:

  1. What is the mechanism by which translation in different mRNA-based environments controls protein activity in the nucleus? 
  2. What is the contribution of 3′UTRs to cellular phenotypes, with a focus on transcription factor and chromatin regulator functions during iPS cell differentiation?
  3. What is the relationship between mRNAs and intrinsically disordered regions (IDRs)? This is based on our findings that mRNAs can act as chaperones for IDRs and can change their conformational states. 
  4. What is the molecular code by which different translation environments control transcription factor and chromatin regulator functions?
  5. Can we develop novel RNA therapeutics to activate or deactivate transcription factors or even target the separate functions of multifunctional transcriptional regulators?

Research Projects

Publications Highlights

Chen, X., Fansler, M.M., Janjoš, U., Ule, J., and Mayr, C. (2024). The FXR1 network acts as signaling scaffold for actomyosin remodeling. Cell, in press. Also on bioRxiv, 2023.2011.2005.565677.

Horste, E.L., Fansler, M.M., Cai, T., Chen, X., Mitschka, S., Zhen, G., Lee, F.C.Y., Ule, J., and Mayr, C. (2023). Subcytoplasmic location of translation controls protein output. Mol Cell 83, 4509-4523.e4511.

Ma W, Zhen G, Xie W, Mayr C. In vivo reconstitution finds multivalent RNA-RNA interactions as drivers of mesh-like condensates. eLife, 10:e64252 (2021). PMID: 33650968

Berkovits BD, Mayr C. Alternative 3’UTRs act as scaffolds to regulate membrane protein localization. Nature 522, 363-367 (2015). Epub 2015 Apr 20. PMID:25896326

View All Publications

People

Christine Mayr

Christine Mayr, MD, PhD

  • Molecular and cell biologist Christine Mayr studies how 3′UTRs regulate protein functions and how mRNAs contribute to cytoplasmic organization.
  • MD, Free University Berlin
  • PhD, Humboldt University Berlin
mayrc@mskcc.org
Email Address
Nadine Hernández
Office Phone
Download CV
PDF File

Members

Xiuzhen Chen
Research Associate
Mervin Fansler
Research Scholar
Research Scholar
Research Technician
Senior Administrative Assistant
Postdoctoral Fellow
Graduate Student
Graduate Student
Shih-Han (Peggy) Lee
Postdoctoral Fellow
Graduate Student
Irtisha Singh
Graduate Student, Tri-I CBM Program
Eric Kallin
Postdoctoral Fellow
Binyamin Berkovits
Postdoctoral Fellow
Ellen Horste
Scientist/Payload Engineer, Apertura Gene Therapy, New York, NY
Marie Clemot
Master Student
Buki Kwon
Postdoctoral Fellow
Omar Hamdani, MPH
Research Technician
Federica Lari
Postdoctoral Fellow
Jessica Johnson
Research Technician
Weirui Ma
Postdoctoral Fellow
Vidur Garg
Research Technician
Sibylle Mitschka
Senior Research Scientist
Neil Patel, Medical School
Research technician
Neil Robertson
Postdoctoral Fellow
Jihye (Sophia)  Lee
Research Technician
Gang Zhen
Postdoctoral Fellow
Pia Worrell
Administrative Assistant
Casey Robinson
Administrative Assistant
Sarah Tisdale
Postdoctoral Fellow

Achievements

  • Luise and Allston Boyer Young Investigator Award for Basic Research (2019)
  • NIH Director’s Pioneer Award (2016)
  • Pershing Square Sohn Prize for Young Investigators in Cancer Research (2015)
  • Damon Runyon-Rachleff Innovation Award, Damon Runyon Cancer Research Foundation (2012)
  • Selected as ‘Cell Scientist to watch’ by Journal of Cell Science (2015)
  • Science Signaling Breakthrough of the year (2013)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Career Opportunities

Apply now

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Christine Mayr discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures